LifeStance Health reports new anxiety medications are expected for 2026, featuring innovative treatments in clinical trials ...

The following guidance is based on the best available evidence. The full guideline gives details of the methods and the evidence used to develop the guidance. People have the right to be involved in ...

Please provide your email address to receive an email when new articles are posted on . Treatment of generalized anxiety disorder with an antidepressant increased the treatment response rate by 41%.

Findings showed the 100mcg dose met the primary endpoint demonstrating a statistically significant 7.6-point reduction in HAM-A score at week 4 compared with placebo. The Food and Drug Administration ...

UCSF is seeking volunteers for a trial using LSD to treat generalized anxiety disorder - a poorly understood and potentially ...

Psychotropic drugs are all the rage now as a potential treatment of brain diseases. Examples are ketamine and psilocybin for depression and PTSD. More recently, a single dose of LSD was found to have ...

In the mental health field, we tend to pathologize and diagnose even commonly encountered challenges. Through the lens of human experience, however, we can recognize that some emotional and mental ...

NEW YORK (Reuters Health) - The results of a study published in the April issue of the Journal of Clinical Psychiatry indicate that treatment with duloxetine, sold under the trade name Cymbalta, ...

Ever felt your heart racing before a big presentation, or maybe butterflies in your stomach when meeting someone new? That's ...

OCD and GAD share symptoms of unwanted thoughts that lead to anxiety and distress. Despite this, the two conditions have significant differences that help tell them apart. Generalized anxiety disorder ...

MELBOURNE, Australia and NEW YORK, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (IXHL) (“Incannex” or the “Company”) is pleased to report positive data from its Phase 2 clinical trial of ...